Matthew WEISS,Thomas DINEEN,Benjamin C. MILGRAM,Isaac E. MARX
申请号：
US16510816
公开号：
US20200009129A1
申请日:
2019.07.12
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The present invention provides compounds of Formula I,and pharmaceutically acceptable salts thereof, that are inhibitors of voltage-gated sodium channels, in particular Nav1.7. The compounds are useful for the treatment of diseases associated with the activity of sodium channels such as pain disorders, cough, and itch. Also provided are pharmaceutical compositions containing compounds of the present invention.
